Pictet Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.16M Sell
106,379
-2,303
-2% -$202K 0.01% 693
2026
Q1
$9.83M Buy
108,682
+674
+0.6% +$61.8K 0.01% 662
2025
Q4
$9.71M Sell
108,008
-7,903
-7% -$749K 0.01% 679
2025
Q3
$11.4M Sell
115,911
-5,898
-5% -$584K 0.01% 641
2025
Q2
$11.1M Buy
121,809
+4,713
+4% +$456K 0.01% 632
2025
Q1
$13.3M Sell
117,096
-3,519
-3% -$376K 0.01% 589
2024
Q4
$12.7M Buy
120,615
+14,609
+14% +$1.57M 0.01% 602
2024
Q3
$11.4M Sell
106,006
-8,414
-7% -$918K 0.01% 616
2024
Q2
$12.4M Buy
114,420
+3,796
+3% +$447K 0.01% 588
2024
Q1
$14.6M Sell
110,624
-255
-0.2% -$31.9K 0.02% 571
2023
Q4
$13.5M Sell
110,879
-771
-0.7% -$86K 0.01% 575
2023
Q3
$12.5M Buy
+111,650
New +$14.2M 0.02% 581

Other funds holding ZBH

Pictet Asset Management's ZBH Position: Q2 2026 in Review

Pictet Asset Management reduced its Zimmer Biomet (ZBH) stake by 2.1% in Q2 2026, selling an estimated $202K and leaving 106,379 shares worth $9.16M. The position accounts for 0.01% of the portfolio, ranked #693.

Pictet Asset Management first reported a position in ZBH in Q3 2023 and has held it in 12 quarters since. The position peaked at $14.6M in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Pictet Asset Management held 106,379 shares of Zimmer Biomet worth $9.16M as of Q2 2026.
  • Pictet Asset Management sold 2,303 Zimmer Biomet shares in Q2 2026, an estimated $202K.
  • Zimmer Biomet made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #693 holding.
  • Pictet Asset Management first reported a position in Zimmer Biomet in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Zimmer Biomet position peaked at $14.6M in Q1 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.